COCH predicts survival and adjuvant TACE response in patients with HCC

The aim of the present study was to measure the expression of Cochlin (COCH) and analyze its association with survival, recurrence and the benefits from adjuvant transarterial chemoembolization (TACE) in patients with hepatocellular carcinoma (HCC) following hepatectomy. Patients with high COCH expr...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Oncol Lett
Auteurs principaux: Wang, Chen, Ding, Zhi-Wen, Zheng, Cheng-Gang, Wang, Siyuan, Li, Zhi-Heng, Zhang, Zi-Mu, Pan, Jian, Wang, Jian, Yang, Chun
Format: Artigo
Langue:Inglês
Publié: D.A. Spandidos 2021
Sujets:
Articles
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC7905559/
https://ncbi.nlm.nih.gov/pubmed/33732351
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/ol.2021.12536
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires